TVM Capital Life Science is a venture capital firm specializing in life sciences, with a focus on therapeutics and medical technologies. Established in 1984, it operates from Munich, Germany, and Montreal, Canada, employing a unique investment strategy that includes a partnership with Eli Lilly.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
TVM Capital Life Science is a venture capital firm dedicated to the life sciences sector, established in 1984 as part of Techno Venture Management. Since 2012, the firm has focused on investing in innovative therapies and medical products that aim to transform healthcare. With offices in Munich, Germany, and Montreal, Canada, TVM Capital Life Science employs a dual-pronged investment strategy. This includes financing early-stage therapeutics through a single asset company approach, leveraging a strategic partnership with Eli Lilly and Company, and investing in differentiated commercial-stage medical technologies and late-stage therapeutics. The firm targets various sectors, including oncology, immunology, and rare diseases, primarily in North America and Europe.
Employing a dual-pronged investment strategy, TVM Capital Life Science finances innovative early-stage therapeutics through a single asset company approach, in partnership with Eli Lilly and Company. The firm also invests in commercial-stage medical technologies, diagnostics, digital health products, and late-stage therapeutics, targeting sectors such as oncology, immunology, diabetes, CNS/neurodegeneration, pain, cardiovascular diseases, and rare diseases.
TVM Capital Life Science adds value to its portfolio companies through strategic partnerships, particularly with Eli Lilly and Company, and by leveraging its extensive industry expertise to guide companies from early development to commercialization.
TVM Capital Life Science focuses on innovative life science products, particularly in the sectors of biotech, healthcare, digital health, medical devices, and diagnostics. The firm invests in early-stage therapeutics and differentiated commercial-stage medical technologies, targeting areas with high unmet medical needs.
Startups can reach out to TVM Capital Life Science via their pitch email at info@tvm-capital.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
TVM Capital Life Science distinguishes itself through its strategic partnership with Eli Lilly, which provides portfolio companies access to significant resources and expertise in drug development. This partnership enhances their single-asset company approach, making it a unique model among European life science VCs.
The firm primarily invests in North America and Europe, focusing on companies that are developing innovative solutions in the life sciences sector.
TVM Capital Life Science manages approximately $900 million in assets under management. The firm invests across various stages, including pre-seed, seed, Series A, Series B, and Series C, with check sizes varying based on the stage and specific investment opportunity.
TVM Capital Life Science actively supports its portfolio companies through its strategic partnership with Eli Lilly, providing guidance and resources in drug development and market positioning. The firm is involved in helping companies navigate the complexities of the life sciences market.
Organizations that do similar work to TVM Capital Life Science.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorAccelerating life sciences innovation in Massachusetts.
InvestorInvesting in the future of life sciences and technology.
InvestorEmpowering high-growth potential companies in Asia-Pacific.
Superscout Pro
Is this page right?Reviewed · How the research works